Clinical Trial Update: Effects of Rosuvastatin on Aortic Stenosis Progression [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether rosuvastatin slows progression of aortic stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Aortic Stenosis | Phase 3 | Status: COMPLETED